Glenmark, AbbVie Ink Licensing Deal for ISB 2001
July 10, 2025 18:02
Glenmark's Ichnos Glenmark inks licensing deal with AbbVie for ISB 2001, a cancer and autoimmune disease drug. AbbVie gets North America, Europe, Japan, Greater China rights; Glenmark retains...